A Phase 3 Open-label Study to Assess the Efficacy, Safety, and Pharmacokinetics of Subcutaneously Administered Ustekinumab in the Treatment of Moderate to Severe Chronic Plaque Psoriasis in Pediatric Subjects 6 to <12 Years of

Project: Research project

Project Details

StatusActive
Effective start/end date3/16/178/31/50

Funding

  • Northwestern University
  • Janssen Research & Development, LLC